Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UKNOWN
UNII: AS3AZ5R46K

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tumor necrosis factor receptor superfamily member 5 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Psoriasis 2 D011565 ClinicalTrials
Glomerulosclerosis, Focal Segmental 2 D005923 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3990028
FDA SRS AS3AZ5R46K